Form 4: Veradigm Inc. Executive Lisa Hammond Reports Acquisition and Disposal of Common Stock

Lisa Hammond, SVP & Chief HR Officer of Veradigm Inc., reports the acquisition of restricted stock units and disposal of common stock on May 31, 2024.

Summary

• Lisa Hammond, SVP & Chief HR Officer of Veradigm Inc., filed a Form 4 on June 20, 2024, reporting changes in beneficial ownership.
• On May 31, 2024, Hammond acquired 52,632 shares of common stock through the award of restricted stock units at a price of $0.
• These restricted stock units vest 33% on each of the first three anniversaries of the grant date.
• On the same day, Hammond disposed of 119,875 shares of common stock.
• Following these transactions, Hammond beneficially owns 119,875 shares of Veradigm Inc. common stock.

Sentiment

Score: 6

Explanation: Neutral sentiment. The acquisition of restricted stock units is generally positive, but the disposal of shares introduces some uncertainty. The overall impact is likely moderate.

Positives

• The acquisition of restricted stock units suggests continued alignment of the executive's interests with the company's long-term performance.

Negatives

• The disposal of 119,875 shares could be interpreted negatively, although the reason for the disposal is not specified in the filing.

Risks

• The Form 4 filing itself doesn't inherently indicate risks, but monitoring insider transactions is crucial for assessing executive sentiment and potential future actions.

Future Outlook

The vesting schedule of the restricted stock units (33% annually for three years) indicates a multi-year incentive structure for the executive.

Industry Context

Insider transactions are routinely monitored in the healthcare technology sector to gauge executive confidence and potential strategic shifts within companies like Veradigm.

Comparison to Industry Standards

• Stock grants are a common form of executive compensation in the tech industry, aligning management interests with shareholder value.
• Companies like Cerner (now Oracle Health) and Allscripts also utilize stock-based compensation to incentivize their executives.
• The vesting schedule of 33% annually is fairly standard, similar to practices observed at companies like Veeva Systems.

Stakeholder Impact

• Shareholders may be interested in the executive's transactions as an indicator of company performance expectations.
• Employees may view the stock grants as a positive sign of the company's commitment to its leadership.

Key Dates